SlideShare a Scribd company logo
1 of 26
Pharmalink Consulting A Brief Overview
Who we are ,[object Object],[object Object],[object Object],[object Object],[object Object]
What we can help with ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Who we work with ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Global Experience ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
How we work ,[object Object],[object Object],[object Object],[object Object],[object Object]
How we work ,[object Object],[object Object],[object Object]
Pharmalink Consulting Case Studies
CLIENT:  A major pharmaceutical company based in Europe PROJECT:  A large product compliance project  OBJECTIVE:  Review all European-registered licenses and bring into  compliance with current manufacturing site practices SOLUTION:  Pharmalink provided a dedicated team of regulatory affairs  specialists to work on the project for 3 years One of the key advantages that Pharmalink was able to bring to the project was the ability to adjust the number of consultants working on  the project to fit the client’s needs and hit every deadline whilst always maintaining the level of quality CASE STUDY 1: Major regulatory compliance project
[object Object],[object Object],[object Object],[object Object],[object Object],CASE STUDY 1: Major regulatory compliance project
CLIENT:  Major pharmaceutical company based in Europe PROJECT:  Review and update of a Module 3 and Quality Overall  Summary for a Biosimilar product in preparation for one of the  first European submissions of its type OBJECTIVE:  Document submission.  Speed to market was of high priority to the client SOLUTION:  Pharmalink  was able to turn to one of its experienced  consultants with a track record specifically with the biotech  product in question Accurate review and submission preparation of the QOS and Module 3  The client could utilize the consultant's advice and make submissions according to the planned timeline CASE STUDY 2: Biosimilar product review
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CASE STUDY 2: Biosimilar product review
CASE STUDY 3: Multinational clinical trial sponsor & Clinical Research Organization CLIENT:  Sponsor and CRO PROJECT:  Provide regulatory support for a clinical trial including new  submissions for the trial in multiple markets OBJECTIVE:  Submit the clinical trial in multiple locations in a timely manner  to allow trial initiation SOLUTION:  Pharmalink provided consultants with valuable local  knowledge to add to the regulatory intelligence of submissions  in each market This project was a testament to the lengths to which the team went to understand the brief and work with the client to achieve their goals
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CASE STUDY 3: Multinational clinical trial sponsor & Clinical Research Organization
CASE STUDY 4: Multinational clinical trial sponsor & Clinical Research Organization ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CASE STUDY 4: Product Compliance Project (External) Large Scale Pharmaceutical Company ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CASE STUDY 4: Multinational clinical trial sponsor & Clinical Research Organization ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CASE STUDY 4: Product Compliance Project (External) Large Scale Pharmaceutical Company PROJECT DETAILS: Dossiers Collected 270 Dossiers Collated 270 Compliance Assessments Performed 270 (10% TPM) Remediation Packages Prepared 564 Markets AT, BE, BU, CH, CY, CZ, DE, DK, EE, EL,ES, FI, FR, HU, IE, IS,  IT, LT, LU, LV, MT, NL, NO,  PL, PO, RO, SE, SK, UK
CASE STUDY 4: Multinational clinical trial sponsor & Clinical Research Organization ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CASE STUDY 4: Product Compliance Project (External) Large Scale Pharmaceutical Company ,[object Object],[object Object],[object Object],[object Object],[object Object]
CASE STUDY 4: Multinational clinical trial sponsor & Clinical Research Organization ,[object Object],[object Object],[object Object],[object Object],[object Object],CASE STUDY 5:  Multiple Abridged License Applications Virtual Pharmaceutical Company
CASE STUDY 4: Multinational clinical trial sponsor & Clinical Research Organization CASE STUDY 5: Multiple Abridged License Application Virtual Pharmaceutical Company ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pharmalink Consulting Additional Information
What else can we offer you? ,[object Object],[object Object],[object Object]
Fees & Pricing ,[object Object],[object Object],[object Object],[object Object]
What Clients say "The project was managed very efficiently by their office-based and on-site staff who are always quick to respond to our needs. We continue to use Pharmalink as our preferred source of consultants for long-term and short-term projects." Large Biotech Company "Many thanks to the Pharmalink project team for doing such a fantastic job. Our MA submissions were delivered very smoothly with impeccable timing." Virtual Pharmaceutical Company   "Each of their staff members have been extremely helpful, efficient, and friendly and have always been willing to go the extra mile to meet our needs." Small Generics Company  "...all projects have been delivered ahead of time or on time. Their experienced and professional approach is mirrored by the resource they supply." Large Generics Manufacturer
[object Object],[object Object],Pharmalink Consulting Our offering in summary
[object Object],[object Object],Pharmalink Consulting Our offering in summary
Thank you ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Chembio - Investor Presentation Aug 2014
Chembio - Investor Presentation Aug 2014Chembio - Investor Presentation Aug 2014
Chembio - Investor Presentation Aug 2014Company Spotlight
 
Quality Auditor and trainerProfile-G.sundar
Quality Auditor and trainerProfile-G.sundarQuality Auditor and trainerProfile-G.sundar
Quality Auditor and trainerProfile-G.sundarG Sundar
 
HealthBIO 2021,_The InFlames Flagship_Timo Veromaa
HealthBIO 2021,_The InFlames Flagship_Timo VeromaaHealthBIO 2021,_The InFlames Flagship_Timo Veromaa
HealthBIO 2021,_The InFlames Flagship_Timo VeromaaBusiness Turku
 
How PerkinElmer became world's market leader?, Marika Kase
How PerkinElmer became world's market leader?, Marika KaseHow PerkinElmer became world's market leader?, Marika Kase
How PerkinElmer became world's market leader?, Marika KaseBusiness Turku
 
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...Business Turku
 
HealthBIO 2020_Tero Piispanen_Turku Science Park
HealthBIO 2020_Tero Piispanen_Turku Science ParkHealthBIO 2020_Tero Piispanen_Turku Science Park
HealthBIO 2020_Tero Piispanen_Turku Science ParkBusiness Turku
 
TGA presentation: Common inspection deficiencies
TGA presentation: Common inspection deficienciesTGA presentation: Common inspection deficiencies
TGA presentation: Common inspection deficienciesTGA Australia
 
Update on Reforms to the Regulatory Framework for Complementary Medicines
Update on Reforms to the Regulatory Framework for Complementary MedicinesUpdate on Reforms to the Regulatory Framework for Complementary Medicines
Update on Reforms to the Regulatory Framework for Complementary MedicinesTGA Australia
 
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...Business Turku
 
C TA - standard operating procedures
C TA - standard operating proceduresC TA - standard operating procedures
C TA - standard operating proceduresDr.RAJEEV KASHYAP
 
FDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
FDA's Case for Quality: What, Why, and How? Changing the Regulatory ParadigmFDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
FDA's Case for Quality: What, Why, and How? Changing the Regulatory ParadigmGreenlight Guru
 
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_BrochureCQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_BrochureKiran Bains
 
Thermo Fisher Introduction
Thermo Fisher IntroductionThermo Fisher Introduction
Thermo Fisher IntroductionKim Bunt
 
Pharma And Biotech Brochure 2009
Pharma And Biotech Brochure 2009Pharma And Biotech Brochure 2009
Pharma And Biotech Brochure 2009tseener
 

What's hot (19)

Chembio - Investor Presentation Aug 2014
Chembio - Investor Presentation Aug 2014Chembio - Investor Presentation Aug 2014
Chembio - Investor Presentation Aug 2014
 
Quality Auditor and trainerProfile-G.sundar
Quality Auditor and trainerProfile-G.sundarQuality Auditor and trainerProfile-G.sundar
Quality Auditor and trainerProfile-G.sundar
 
HealthBIO 2021,_The InFlames Flagship_Timo Veromaa
HealthBIO 2021,_The InFlames Flagship_Timo VeromaaHealthBIO 2021,_The InFlames Flagship_Timo Veromaa
HealthBIO 2021,_The InFlames Flagship_Timo Veromaa
 
PRCCI Newsletter Issue 21
PRCCI Newsletter Issue 21 PRCCI Newsletter Issue 21
PRCCI Newsletter Issue 21
 
How PerkinElmer became world's market leader?, Marika Kase
How PerkinElmer became world's market leader?, Marika KaseHow PerkinElmer became world's market leader?, Marika Kase
How PerkinElmer became world's market leader?, Marika Kase
 
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
 
Epitome Corporate PPT
Epitome Corporate PPTEpitome Corporate PPT
Epitome Corporate PPT
 
HealthBIO 2020_Tero Piispanen_Turku Science Park
HealthBIO 2020_Tero Piispanen_Turku Science ParkHealthBIO 2020_Tero Piispanen_Turku Science Park
HealthBIO 2020_Tero Piispanen_Turku Science Park
 
TGA presentation: Common inspection deficiencies
TGA presentation: Common inspection deficienciesTGA presentation: Common inspection deficiencies
TGA presentation: Common inspection deficiencies
 
Update on Reforms to the Regulatory Framework for Complementary Medicines
Update on Reforms to the Regulatory Framework for Complementary MedicinesUpdate on Reforms to the Regulatory Framework for Complementary Medicines
Update on Reforms to the Regulatory Framework for Complementary Medicines
 
Prof. Melissa Hanna-Brown
Prof. Melissa Hanna-BrownProf. Melissa Hanna-Brown
Prof. Melissa Hanna-Brown
 
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...
 
C TA - standard operating procedures
C TA - standard operating proceduresC TA - standard operating procedures
C TA - standard operating procedures
 
FDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
FDA's Case for Quality: What, Why, and How? Changing the Regulatory ParadigmFDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
FDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
 
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
 
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_BrochureCQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
 
DCN Company Profile 2015
DCN Company Profile 2015DCN Company Profile 2015
DCN Company Profile 2015
 
Thermo Fisher Introduction
Thermo Fisher IntroductionThermo Fisher Introduction
Thermo Fisher Introduction
 
Pharma And Biotech Brochure 2009
Pharma And Biotech Brochure 2009Pharma And Biotech Brochure 2009
Pharma And Biotech Brochure 2009
 

Viewers also liked

20080208 Dia Edm Maximizing Metadata Oberhofer
20080208 Dia Edm Maximizing Metadata Oberhofer20080208 Dia Edm Maximizing Metadata Oberhofer
20080208 Dia Edm Maximizing Metadata Oberhoferoberhofer
 
Informa Life Sciences’ Inaugural Conference on e-Submissions
Informa Life Sciences’ Inaugural Conference on e-SubmissionsInforma Life Sciences’ Inaugural Conference on e-Submissions
Informa Life Sciences’ Inaugural Conference on e-Submissionsseront
 
Presentation on regulatory affairs 30032013
Presentation on regulatory affairs 30032013Presentation on regulatory affairs 30032013
Presentation on regulatory affairs 30032013Nishodh Saxena Ph. D.
 

Viewers also liked (6)

20080208 Dia Edm Maximizing Metadata Oberhofer
20080208 Dia Edm Maximizing Metadata Oberhofer20080208 Dia Edm Maximizing Metadata Oberhofer
20080208 Dia Edm Maximizing Metadata Oberhofer
 
eCTD
eCTDeCTD
eCTD
 
Informa Life Sciences’ Inaugural Conference on e-Submissions
Informa Life Sciences’ Inaugural Conference on e-SubmissionsInforma Life Sciences’ Inaugural Conference on e-Submissions
Informa Life Sciences’ Inaugural Conference on e-Submissions
 
Common Technical Document : A Regulatory Document
Common Technical Document  : A Regulatory DocumentCommon Technical Document  : A Regulatory Document
Common Technical Document : A Regulatory Document
 
XML and DTD
XML and DTDXML and DTD
XML and DTD
 
Presentation on regulatory affairs 30032013
Presentation on regulatory affairs 30032013Presentation on regulatory affairs 30032013
Presentation on regulatory affairs 30032013
 

Similar to Learn More About Pharmalink

Learn More About Pharmalink
Learn More About PharmalinkLearn More About Pharmalink
Learn More About Pharmalinkasheeshb
 
Product Compliance Project Case Study
Product Compliance Project    Case StudyProduct Compliance Project    Case Study
Product Compliance Project Case StudyKotoole
 
Regulatory Compliance Project Case Study
Regulatory Compliance Project    Case StudyRegulatory Compliance Project    Case Study
Regulatory Compliance Project Case StudyKotoole
 
APT_Indigo FactSheet FINAL
APT_Indigo FactSheet FINALAPT_Indigo FactSheet FINAL
APT_Indigo FactSheet FINALTim Calvert
 
Nearly the Holy Grail – Clinical Portals for Faster, Better and Borderless Care
Nearly the Holy Grail – Clinical Portals for Faster, Better and Borderless CareNearly the Holy Grail – Clinical Portals for Faster, Better and Borderless Care
Nearly the Holy Grail – Clinical Portals for Faster, Better and Borderless CareNHSScotlandEvent
 
Presentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection ProgramPresentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection ProgramTGA Australia
 
Next generation family diagnostic analysers
Next generation family diagnostic analysersNext generation family diagnostic analysers
Next generation family diagnostic analysersSylwia Borawska
 
Amit_Kumar_15052015_AG
Amit_Kumar_15052015_AGAmit_Kumar_15052015_AG
Amit_Kumar_15052015_AGAmit Kumar
 
EU CTR Compliance and Success Navigating Updates and Preparing Submissions fo...
EU CTR Compliance and Success Navigating Updates and Preparing Submissions fo...EU CTR Compliance and Success Navigating Updates and Preparing Submissions fo...
EU CTR Compliance and Success Navigating Updates and Preparing Submissions fo...MMS Holdings
 
Concept to Commercialization- Health & Wellness Product
Concept to Commercialization- Health & Wellness Product Concept to Commercialization- Health & Wellness Product
Concept to Commercialization- Health & Wellness Product Stabicon Life Sciences Pvt. Ltd
 
OneStart Top 10 Finalists
OneStart Top 10 FinalistsOneStart Top 10 Finalists
OneStart Top 10 Finalistsjohndaley89
 
One start finalists
One start finalistsOne start finalists
One start finalistsjohndaley89
 
Together for sustainability -
Together for sustainability -Together for sustainability -
Together for sustainability -ericris
 
Company Presentation Final June 2008
Company Presentation   Final June 2008Company Presentation   Final June 2008
Company Presentation Final June 2008lspeid
 

Similar to Learn More About Pharmalink (20)

Learn More About Pharmalink
Learn More About PharmalinkLearn More About Pharmalink
Learn More About Pharmalink
 
Product Compliance Project Case Study
Product Compliance Project    Case StudyProduct Compliance Project    Case Study
Product Compliance Project Case Study
 
Stabicon Corporate Presentation
Stabicon Corporate PresentationStabicon Corporate Presentation
Stabicon Corporate Presentation
 
Regulatory Compliance Project Case Study
Regulatory Compliance Project    Case StudyRegulatory Compliance Project    Case Study
Regulatory Compliance Project Case Study
 
APT_Indigo FactSheet FINAL
APT_Indigo FactSheet FINALAPT_Indigo FactSheet FINAL
APT_Indigo FactSheet FINAL
 
Nearly the Holy Grail – Clinical Portals for Faster, Better and Borderless Care
Nearly the Holy Grail – Clinical Portals for Faster, Better and Borderless CareNearly the Holy Grail – Clinical Portals for Faster, Better and Borderless Care
Nearly the Holy Grail – Clinical Portals for Faster, Better and Borderless Care
 
Presentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection ProgramPresentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection Program
 
Regulatory1
Regulatory1Regulatory1
Regulatory1
 
Next generation family diagnostic analysers
Next generation family diagnostic analysersNext generation family diagnostic analysers
Next generation family diagnostic analysers
 
Amit_Kumar_15052015_AG
Amit_Kumar_15052015_AGAmit_Kumar_15052015_AG
Amit_Kumar_15052015_AG
 
About Compliance Insight Inc.
About Compliance Insight Inc.About Compliance Insight Inc.
About Compliance Insight Inc.
 
Popsi Cube 2011
Popsi Cube 2011Popsi Cube 2011
Popsi Cube 2011
 
EU CTR Compliance and Success Navigating Updates and Preparing Submissions fo...
EU CTR Compliance and Success Navigating Updates and Preparing Submissions fo...EU CTR Compliance and Success Navigating Updates and Preparing Submissions fo...
EU CTR Compliance and Success Navigating Updates and Preparing Submissions fo...
 
Concept to Commercialization- Health & Wellness Product
Concept to Commercialization- Health & Wellness Product Concept to Commercialization- Health & Wellness Product
Concept to Commercialization- Health & Wellness Product
 
Concept to Commercialization Health & Wellness Product
Concept to Commercialization Health & Wellness Product Concept to Commercialization Health & Wellness Product
Concept to Commercialization Health & Wellness Product
 
ICH & It's Guidelines
ICH & It's GuidelinesICH & It's Guidelines
ICH & It's Guidelines
 
OneStart Top 10 Finalists
OneStart Top 10 FinalistsOneStart Top 10 Finalists
OneStart Top 10 Finalists
 
One start finalists
One start finalistsOne start finalists
One start finalists
 
Together for sustainability -
Together for sustainability -Together for sustainability -
Together for sustainability -
 
Company Presentation Final June 2008
Company Presentation   Final June 2008Company Presentation   Final June 2008
Company Presentation Final June 2008
 

Recently uploaded

Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Available
Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service AvailableBerhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Available
Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Availablepr788182
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1kcpayne
 
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...pujan9679
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxDitasDelaCruz
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingNauman Safdar
 
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTSDurg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTSkajalroy875762
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwaitdaisycvs
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGpr788182
 
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service AvailableNashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Availablepr788182
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...daisycvs
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Adnet Communications
 
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book nowGUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book nowkapoorjyoti4444
 
PARK STREET 💋 Call Girl 9827461493 Call Girls in Escort service book now
PARK STREET 💋 Call Girl 9827461493 Call Girls in  Escort service book nowPARK STREET 💋 Call Girl 9827461493 Call Girls in  Escort service book now
PARK STREET 💋 Call Girl 9827461493 Call Girls in Escort service book nowkapoorjyoti4444
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityEric T. Tung
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxCynthia Clay
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 MonthsIndeedSEO
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistanvineshkumarsajnani12
 
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...meghakumariji156
 

Recently uploaded (20)

HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024
 
Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Available
Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service AvailableBerhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Available
Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Available
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1
 
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
 
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTSDurg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
Durg CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN durg ESCORTS
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service AvailableNashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book nowGUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book now
 
PARK STREET 💋 Call Girl 9827461493 Call Girls in Escort service book now
PARK STREET 💋 Call Girl 9827461493 Call Girls in  Escort service book nowPARK STREET 💋 Call Girl 9827461493 Call Girls in  Escort service book now
PARK STREET 💋 Call Girl 9827461493 Call Girls in Escort service book now
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League City
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
 
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
 

Learn More About Pharmalink

  • 1. Pharmalink Consulting A Brief Overview
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 9. CLIENT: A major pharmaceutical company based in Europe PROJECT: A large product compliance project OBJECTIVE: Review all European-registered licenses and bring into compliance with current manufacturing site practices SOLUTION: Pharmalink provided a dedicated team of regulatory affairs specialists to work on the project for 3 years One of the key advantages that Pharmalink was able to bring to the project was the ability to adjust the number of consultants working on the project to fit the client’s needs and hit every deadline whilst always maintaining the level of quality CASE STUDY 1: Major regulatory compliance project
  • 10.
  • 11. CLIENT: Major pharmaceutical company based in Europe PROJECT: Review and update of a Module 3 and Quality Overall Summary for a Biosimilar product in preparation for one of the first European submissions of its type OBJECTIVE: Document submission. Speed to market was of high priority to the client SOLUTION: Pharmalink was able to turn to one of its experienced consultants with a track record specifically with the biotech product in question Accurate review and submission preparation of the QOS and Module 3 The client could utilize the consultant's advice and make submissions according to the planned timeline CASE STUDY 2: Biosimilar product review
  • 12.
  • 13. CASE STUDY 3: Multinational clinical trial sponsor & Clinical Research Organization CLIENT: Sponsor and CRO PROJECT: Provide regulatory support for a clinical trial including new submissions for the trial in multiple markets OBJECTIVE: Submit the clinical trial in multiple locations in a timely manner to allow trial initiation SOLUTION: Pharmalink provided consultants with valuable local knowledge to add to the regulatory intelligence of submissions in each market This project was a testament to the lengths to which the team went to understand the brief and work with the client to achieve their goals
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 21.
  • 22.
  • 23. What Clients say "The project was managed very efficiently by their office-based and on-site staff who are always quick to respond to our needs. We continue to use Pharmalink as our preferred source of consultants for long-term and short-term projects." Large Biotech Company "Many thanks to the Pharmalink project team for doing such a fantastic job. Our MA submissions were delivered very smoothly with impeccable timing." Virtual Pharmaceutical Company "Each of their staff members have been extremely helpful, efficient, and friendly and have always been willing to go the extra mile to meet our needs." Small Generics Company "...all projects have been delivered ahead of time or on time. Their experienced and professional approach is mirrored by the resource they supply." Large Generics Manufacturer
  • 24.
  • 25.
  • 26.